Get subscribed to our newsletter
Get interesting updates to your email inbox.
It may appear strange but more self-employed people are committing suicide every day than the unemployed. People with their own startups are likely to be depressed.
It may be a testimony to the bleak economic situation and the slump in various industries that an average of 36 self-employed people ended their lives every day as against a lesser number of 35 unemployed people.
While the government has been offering several categories of loans for the self-employed, the downturn in commercial activity in general, indebtedness and the stress of running a business may be taking a toll on the self-employed. Self-employed category accounted for 9.8 per cent of total suicide victims (13,149 out of 1,34,516).
Suicides by the self-employed and the unemployed in 2018, with the two categories together accounted for 26,085 deaths during the year, according to government data. The self employed figure of suicides at 13,149 is more than the suicides by the unemployed at 12,936.
Both the categories combined outnumbered the suicide figures of those working in the farming sector at 10,349 in 2018, according to data compiled by the National Crime Records Bureau (NCRB).
“Each suicide is a personal tragedy that prematurely takes the life of an individual and has a continuing ripple effect, dramatically affecting the lives of families, friends and communities. Every year, more than 1 lakh people commit suicide in our country. There are various causes of suicides like professional/career problems, sense of isolation, abuse, violence, family problems, mental disorders, addiction to alcohol, financial loss, chronic pain etc,” says the NCRB adding it collects data on suicides from police recorded suicide cases.
A total of 1.34 lakh suicides were reported in the country during 2018, showing an increase of 3.6 per cent in comparison to 2017. The rate of suicides, which means deaths per one lakh population, also increased by 0.3 per cent during 2018 over 2017, the NCRB stated.
In a shocking revelation, one unemployed person committed suicide every hour during 2018. Of the total suicides, 92,114 male and 42,391 female, were reported in the country, NCRB’s data on “Suicide in India-2018” says.
The latest data, issued by the National Crime Records Bureau (NCRB) under Ministry of Home Affairs, reveals that a total of 12,936 unemployed persons committed suicide in 2018, which accounted for the 9.6 per cent of the total suicides, were of aged below 18 years to above 60 years.
Those below 18 years include 31 males and nine females while those between 18 and 30 years comprise 1,240 male and 180 female. A total of 868 male and 95 female were aged between 30 and 45 years. A number of 237 males and 21 females were aged between 45 and 60 years while 2,431 males and 310 females were above 60 years. Of the total suicides by unemployed persons, males are 10,687 while the females are 2,249.4
Majority of 12.3 per cent suicides committed by unemployed persons were in Kerala (1,585 out of 12,936 suicides), 12.2 per cent in Tamil Nadu (1,579 suicides), 9.7 per cent in Maharashtra (1,260 suicides), 8.5 per cent in Karnataka (1,094 suicides) and 7 per cent in Uttar Pradesh (902 suicides). (IANS)
A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study that was looking for existing drugs that could be repurposed to treat coronavirus.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
They've shared the results with the U.S. National Institutes of Health, which publishes treatment guidelines, and they hope for a World Health Organization recommendation.
"If WHO recommends this, you will see it widely taken up," said study co-author Dr. Edward Mills of McMaster University in Hamilton, Ontario, adding that many poor nations have the drug readily available. "We hope it will lead to a lot of lives saved."
The pill, called fluvoxamine, would cost $4 for a course of COVID-19 treatment. By comparison, antibody IV treatments cost about $2,000 and Merck's experimental antiviral pill for COVID-19 is about $700 per course. Some experts predict various treatments eventually will be used in combination to fight the coronavirus.
Researchers tested the antidepressant in nearly 1,500 Brazilians recently infected with coronavirus who were at risk of severe illness because of other health problems, such as diabetes. About half took the antidepressant at home for 10 days, the rest got dummy pills. They were tracked for four weeks to see who landed in the hospital or spent extended time in an emergency room when hospitals were full.
In the group that took the drug, 11% needed hospitalization or an extended ER stay, compared to 16% of those on dummy pills.
The results, published Wednesday in the journal Lancet Global Health, were so strong that independent experts monitoring the study recommended stopping it early because the results were clear.
Questions remain about the best dosing, whether lower risk patients might also benefit and whether the pill should be combined with other treatments.
The larger project looked at eight existing drugs to see if they could work against the pandemic virus. The project is still testing a hepatitis drug, but all the others — including metformin, hydroxychloroquine and ivermectin — haven't panned out.
The cheap generic and Merck's COVID-19 pill work in different ways and "may be complementary," said Dr. Paul Sax of Brigham and Women's Hospital and Harvard Medical School, who was not involved in the study. Earlier this month, Merck asked regulators in the U.S. and Europe to authorize its antiviral pill. (VOA/RN)
Keywords: Antidepressant, Early COVID, Pandemic, Testing project
Even one of the world's most powerful tech CEOs can forget to unmute himself during a video chat. For Alphabet and Google CEO Sundar Pichai, one such embarrassing moment came as he began the chat with Kermit The Frog, a character from Muppets, on Google Meet recently. Sharing the two-minute video clip on Twitter on Wednesday, Pichai said: "Always remember to unmute thanks @KermitTheFrog for joining us on @YouTube #DearEarth and chatting about some of our shared interests."
The video was part of YouTube's "Dear Earth" series which aims to address climate challenges. "Hi there, Sundar," said Kermit, a Muppet character created in 1955, to which, Pichai replied but he was inaudible as he was on mute. "Sundar, I think you are on mute. Wow, can't believe I am talking to the CEO of Google, and he is on mute," Kermit said.
At that point, Pichai realised he was on mute. "Sorry, Kermit. I was on mute, and I've done it a few times this year like everyone else. I'm a huge fan of you and the muppets," replied the Google CEO. The video chat went smooth after the opening glitch, and Kermit The Frog and Pichai spoke about climate issues the world is grappling with. (IANS/ MBI)
Keywords: Google CEO Sundar Pichai, google meet, Kermit, dear earth, Alphabet and Google CEO.
A person's disapproval of noncommittal sex and their condemnation of recreational drug use may have a common genetic basis, suggests a study. The research, published in the journal Psychological Science, showed that moral views concerning both recreational drugs and openness to non-committed sex are approximately 50 per cent heritable, with the remaining 50 per cent explained by the unique environment.
Furthermore, approximately 75 per cent of the relationship between openness to non-committed sex and moral views concerning recreational drugs was explained by genetic effects, and the remainder was explained by the unique environment. "People adopt behaviours and attitudes, including certain moral views, that are advantageous to their own interests," said lead author Annika Karinen, a researcher at Vrije Universiteit Amsterdam in the Netherlands.
A person's disapproval of noncommittal sex and their condemnation of recreational drug use may have a common genetic basis, suggests a study. | Photo by Braňo on Unsplash
"People tend to associate recreational drug use with non-committed sex. As such, people who are heavily oriented toward high commitment in sexual relationships morally condemn recreational drugs, as they benefit from environments in which high sexual commitment is the norm," she added. The researchers also found substantial overlap in the genetic effects underlying both factors - namely, that approximately 40 per cent of the genes underlying openness to non-committed sex also underlie moral views concerning recreational drugs.
"These findings suggest that the genetic effects that influence openness to non-committed sex overlap with those that influence moral views concerning recreational drugs," said Karinen. "Important parts of hot-button culture-war issues flow from differences in lifestyle preferences between people, and those differences in lifestyle preferences appear to partly have a genetic basis."
To understand the hereditary and environmental factors, the team surveyed 8,118 Finnish fraternal and identical twins to examine how open they were to recreational drug use and to sex outside of a committed relationship. The researchers then compared fraternal and identical twin pairs to assess the extent to which condemnation of recreational drugs, openness to non-committal sex, and the relationship between the two was explained by genes; the shared environment such as growing up in the same household or community; or unique experiences and environments not shared by the twins. (IANS/ MBI)
Keywords: genes, determine, moral, values, drug, sex, genetic, environment